Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  tenofovir
Find trials that include:  Any drugs shown
Trial Status:  Active
Results 1-7 of 7 for your search:
Start Over
Prophylaxis of CHB Patients With Malignant Tumor Receiving Chemotherapy
Phase: Phase IV
Type: Supportive care
Status: Active
Age: 18 to 70
Sponsor: Other
Protocol IDs: IN-US-174-0207, NCT02081469
Antiretroviral Therapy (ART) Alone or With Delayed Chemo Versus ART With Immediate Chemo for Limited AIDS-related Kaposi's Sarcoma
Phase: Phase III
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: ACTG A5264, 1U01AI068636, NCT01352117
Three Chemo Regimens as an Adjunct to ART for Treatment of Advanced AIDS-KS
Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: ACTG A5263, 1U01AI068636, U01CA121947, NCT01435018
Tenofovir to Prevent HBV Reactivation
Phase: Phase III
Type: Supportive care
Status: Approved-not yet active
Age: 18 and over
Sponsor: Other
Protocol IDs: JF62014, NCT02186574
Safety & Efficacy of Lamivudine & Tenofovir to Lower Plasma Level of Viral RNA in Lymphoma
Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Approved-not yet active
Age: 18 and over
Sponsor: Other
Protocol IDs: UMCC 2010 097, HUM 33361, NCT01528865
PROLIFICA - West African Treatment Cohort for Hepatitis B
Phase: No phase specified
Type: Natural history/Epidemiology, Screening
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: WMDH-P34114, NCT02129829
An Observational Study on Evaluating the Efficacy and Safety of Preemptive Antiviral Therapy With Tenofovir in HBsAg-positive Patients With Diffuse Large B-cell Lymphoma Receiving Rituximab-CHOP Chemotherapy (SPEED Study)
Phase: No phase specified
Type: Natural history/Epidemiology
Status: Approved-not yet active
Age: 18 and over
Sponsor: Other
Protocol IDs: 4-2014-0928, NCT02354846
Start Over